NCT04628793 - A Study of Single Ascending Doses of PF-07258669 in Healthy Adult Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 16, 2021

Primary Completion Date

August 25, 2021

Study Completion Date

August 25, 2021

Conditions

Healthy Participants

Interventions

DRUG

PF-07258669

PF-07258669 will be prepared as an oral solution and/or suspension given in escalating single doses to be determined

DRUG

Placebo

Matching placebo will be prepared as an oral solution and/or suspension given in each cohort

Trial Locations (1)

QPS-MRA, LLC-Main Office, South Miami